Bclaf1 regulates c-FLIP expression and protects cells from TNF-induced apoptosis and tissue injury

EMBO Rep. 2022 Jan 5;23(1):e52702. doi: 10.15252/embr.202152702. Epub 2021 Oct 25.

Abstract

TNF stimulation generates pro-survival signals through activation of NF-κB that restrict the build-in death signaling triggered by TNF. The competition between TNF-induced survival and death signals ultimately determines the fate of a cell. Here, we report the identification of Bclaf1 as a novel component of the anti-apoptotic program of TNF. Bclaf1 depletion in multiple cells sensitizes cells to TNF-induced apoptosis but not to necroptosis. Bclaf1 exerts its anti-apoptotic function by promoting the transcription of CFLAR, a caspase 8 antagonist, downstream of NF-κB activation. Bclaf1 binds to the p50 subunit of NF-κB, which is required for Bclaf1 to stimulate CFLAR transcription. Finally, in Bclaf1 siRNA administered mice, TNF-induced small intestine injury is much more severe than in control mice with aggravated signs of apoptosis and pyroptosis. These results suggest Bclaf1 is a key regulator in TNF-induced apoptosis, both in vitro and in vivo.

Keywords: Bclaf1; TNF; apoptosis; c-FLIP.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis* / genetics
  • CASP8 and FADD-Like Apoptosis Regulating Protein* / biosynthesis
  • CASP8 and FADD-Like Apoptosis Regulating Protein* / genetics
  • Intestine, Small / injuries
  • Intestine, Small / metabolism
  • Intestine, Small / physiopathology
  • Mice
  • NF-kappa B* / genetics
  • NF-kappa B* / metabolism
  • Repressor Proteins* / genetics
  • Signal Transduction
  • Tumor Necrosis Factor-alpha* / pharmacology

Substances

  • Bclaf1 protein, mouse
  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • Cflar protein, mouse
  • NF-kappa B
  • Repressor Proteins
  • Tumor Necrosis Factor-alpha